|
C11ORF82 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.138200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.055000E-01 |
| Normal-vs-Stage2 |
4.375400E-01 |
| Normal-vs-Stage3 |
1.450560E-01 |
| Normal-vs-Stage4 |
1.321580E-02 |
| Stage1-vs-Stage2 |
8.917400E-01 |
| Stage1-vs-Stage3 |
1.225800E-01 |
| Stage1-vs-Stage4 |
1.968500E-02 |
| Stage2-vs-Stage3 |
4.226800E-01 |
| Stage2-vs-Stage4 |
3.190100E-02 |
| Stage3-vs-Stage4 |
5.466300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.187600E-02 |
| Normal-vs-AfricanAmerican |
7.081800E-01 |
| Normal-vs-Asian |
4.683600E-01 |
| Caucasian-vs-AfricanAmerican |
7.972300E-02 |
| Caucasian-vs-Asian |
9.075600E-01 |
| AfricanAmerican-vs-Asian |
3.782600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.623800E-02 |
| Normal-vs-Female |
2.479400E-01 |
| Male-vs-Female |
1.762560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.525380E-01 |
| Normal-vs-Age(41-60Yrs) |
1.362600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.150810E-01 |
| Normal-vs-Age(81-100Yrs) |
9.764400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.941400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.560800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.232580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.226400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.285700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.149770E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.971000E-01 |
| Normal-vs-Grade 2 |
4.188200E-01 |
| Normal-vs-Grade 3 |
2.570600E-01 |
| Normal-vs-Grade 4 |
5.479400E-03 |
| Grade 1-vs-Grade 2 |
2.336000E-01 |
| Grade 1-vs-Grade 3 |
4.442300E-02 |
| Grade 1-vs-Grade 4 |
2.236600E-03 |
| Grade 2-vs-Grade 3 |
3.290800E-01 |
| Grade 2-vs-Grade 4 |
7.899700E-03 |
| Grade 3-vs-Grade 4 |
1.260320E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.592800E-01 |
| Normal-vs-ccB subtype |
1.169970E-02 |
| ccA subtype-vs-ccB subtype |
6.37929999999232E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.301410E-01 |
| Normal-vs-N1 |
5.115500E-03 |
| N0-vs-N1 |
2.778400E-02 |
|
|
